Neola Medical Ab Stock Fundamentals
| NEOLA Stock | 2.20 0.08 3.51% |
Neola Medical AB fundamentals help investors to digest information that contributes to Neola Medical's financial success or failures. It also enables traders to predict the movement of Neola Stock. The fundamental analysis module provides a way to measure Neola Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neola Medical stock.
Neola |
Neola Medical AB Company Return On Equity Analysis
Neola Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Neola Medical Return On Equity | -0.23 |
Most of Neola Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neola Medical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Neola Medical AB has a Return On Equity of -0.2268. This is 99.05% lower than that of the Healthcare sector and 97.4% lower than that of the Medical Devices industry. The return on equity for all Sweden stocks is 26.84% lower than that of the firm.
Neola Medical AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Neola Medical's current stock value. Our valuation model uses many indicators to compare Neola Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neola Medical competition to find correlations between indicators driving Neola Medical's intrinsic value. More Info.Neola Medical AB is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Neola Medical's earnings, one of the primary drivers of an investment's value.Neola Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neola Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neola Medical could also be used in its relative valuation, which is a method of valuing Neola Medical by comparing valuation metrics of similar companies.Neola Medical is currently under evaluation in return on equity category among its peers.
Neola Fundamentals
| Return On Equity | -0.23 | |||
| Return On Asset | -0.12 | |||
| Profit Margin | (0.82) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 69.42 M | |||
| Shares Outstanding | 55.69 M | |||
| Shares Owned By Insiders | 72.57 % | |||
| Shares Owned By Institutions | 4.33 % | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 7.03 X | |||
| Revenue | 11.05 M | |||
| Gross Profit | 9.77 M | |||
| EBITDA | (8.59 M) | |||
| Book Value Per Share | 1.58 X | |||
| Beta | 0.86 | |||
| Market Capitalization | 114.46 M |
About Neola Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neola Medical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neola Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neola Medical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Neola Stock Analysis
When running Neola Medical's price analysis, check to measure Neola Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neola Medical is operating at the current time. Most of Neola Medical's value examination focuses on studying past and present price action to predict the probability of Neola Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neola Medical's price. Additionally, you may evaluate how the addition of Neola Medical to your portfolios can decrease your overall portfolio volatility.